来自图书识别和生物信息学分析的结合证据确定miR-21是糖尿病潜在的治疗点
Yiqing Chen1,2, Xuan Ye1,2, Xiao Zhang1
1Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and Shanghai Engineering Research Center of Organ Repair, School of Life Science, Shanghai University, Nantong 226011, China.
Metabolites
|August 28, 2024
概括
微RNA (miRNA) 在糖尿病研究中至关重要. 这项研究确定了miR-21作为一个关键的上调分子,突出了它在糖尿病治疗中的治疗潜力.
科学领域:
- 生物医学研究的研究.
- 遗传学 遗传学 是一个
- 内分泌学 在内分泌学.
背景情况:
- 微RNAs (miRNAs) 越来越多地被认为是它们在糖尿病中的作用.
- 确定特定的治疗性miRNA标仍然是一个挑战.
研究的目的:
- 分析与糖尿病相关的miRNA的研究趋势.
- 为了确定具有糖尿病治疗潜力的特定miRNA分子.
主要方法:
- 采用了综合的文献识别和生物信息学分析.
- 主要的研究机构,作者,引用的参考文献和关键字被可视化.
- 生物信息学分析在糖尿病患者中发现了显著上调的miRNA.
主要成果:
- 与糖尿病有关的miRNA研究是一个快速增长的领域,出版物越来越多.
- 常见的关键词包括miR-21,miR-146a,miR-155和miR-34a.
- 生物信息学分析证实miR-21在糖尿病中显著上调,并与其病变产生有关.
结论:
- miR-21成为糖尿病治疗的非常有前途的治疗点.
- 这项研究为确定miRNA临床翻译目标提供了一个框架.
- 未来的研究应该专注于涉及糖尿病治疗miR-21的治疗策略.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


